Grant Campany

Grant Campany has a diverse work experience in the life sciences industry. Grant has held various leadership positions in different companies and organizations.

In 2003, they worked as a Strategist for Portfolio Impact & Evaluation at the Gordon and Betty Moore Foundation. From 2007 to 2010, they served as a Life Science Strategist at B LOGiQ Consultancy.

Grant then joined the FDA in 2012 as an Entrepreneur-in-Residence (EIR) Fellow. Grant later transitioned to Microdermics, where they worked as the Interim CEO from 2015 to 2018.

In 2018, Grant joined Yinuoke Biopharma as the Chief Business Officer. Grant held this position until 2021.

From 2010 to 2020, Grant worked at XPRIZE as the Executive Director | Life Sciences.

In 2020, Grant took on the role of Start-Up Mentor at Ureeka.

In late 2020, they became the Interim CEO at Renovar Bio, Inc. and held the position until mid-2022.

In 2022, Grant held two concurrent positions as the Chief Business Advisor at AceLink Therapeutics and as the Interim CFO at NemaLife, Inc.

Grant Campany holds a Master of Business Administration (MBA) degree in Banking, Corporate, Finance, and Securities Law from the University of Minnesota - Carlson School of Management. Grant also obtained a Bachelor of Science in Business (BSB) degree with a focus on Biology & Strategic Marketing from the same institution. In addition to their degrees, Grant has earned certifications in "The Six Morning Habits of High Performers" from LinkedIn and "Artificial Intelligence Foundations: Machine Learning" from LinkedIn e-learning.